Browse studies

Find your next paid study

27,288 recruiting studies available now

Application of a 5% Lidocaine Ointment to Endotracheal Tubes to Reduce Emergence Bucking: a Randomized Double-Blind Prospective Trial.

This prospective, randomized, double-blind, two-arm clinical trial will evaluate whether applying 5% lidocaine ointment to endotracheal tubes before intubation…

Emergency Coughing

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Ohio State UniversityNCT07709390

Phase 2

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

The purpose of this study is to determine if experimental drug treatment improves recovery after TBI as compared to a control (placebo) group. Changes in recov…

Traumatic Brain Injury

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT05826912

Phase 2

Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications in People With T1D (Precision T1D Platform)

Breakthrough T1D has awarded support for a joint University of Michigan-Oregon Health \& Science University Center of Excellence (CoE) to address cardio-renal …

Type 1 DiabetesT1D Heart FailureCardio-renal Vascular Function and Failure+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Oregon Health and Science UniversityNCT07594145

Observational

Evaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury

Depression is a leading cause of disability worldwide and is more commonly seen in individual's post-spinal cord injury (SCI) than in the general population. D…

Spinal Cord InjuriesDepressionDepressive Disorder, Major

Estimated

~$10 – $675

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT05553353

Observational

EarFlo: A Non-Invasive Treatment for Otitis Media With Effusion & Eustachian Tube Dysfunction in Adults

This study evaluates the use of the EarFlo device in adults with clinically confirmed Eustachian tube dysfunction and/or otitis media with effusion. The purpos…

Otitis Media With Effusion (OME)Eustachian Tube DysfunctionOtitis Media With Effusion

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Philip PerezNCT07777302

Phase 4

Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients

This goal of this study is to assess the safety and immunogenicity of recombinant zoster virus in young adult solid organ transplant recipients. In this study,…

Varicella Zoster

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Ann & Robert H Lurie Children's Hospital of ChicagoNCT06162494

Phase 3

A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn's Disease

The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of m…

Crohn's Disease

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Janssen Research & Development, LLCNCT05923073

Phase 3

A Phase 3 Clinical Trial to Compare Efficacy, Safety, Tolerability and Immunogenicity of RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration

This clinical study is designed to demonstrate the equivalence of the two Investigational Products by comparing the efficacy, safety, tolerability and immunoge…

Neovascular Age-related Macular Degeneration (nAMD)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Rophibio, Inc.NCT06470373

Observational

Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever: Efficacy and Safety

This study is focused on investigating the efficacy and safety of the FlowTriever device to treat low-risk submassive pulmonary embolism.

Pulmonary Embolism

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Northwell HealthNCT05273762

Phase 1

A Phase I Study to Investigate the Safety of the Ubiquitin Activating Enzyme Inhibitor TAK-243 in Adult Solid Tumor and Lymphoma Patients

This phase I trial studies the side effects and best dose of ubiquitin-activating enzyme (UAE) inhibitor TAK-243 (TAK-243) in treating patients with a solid tu…

Advanced LymphomaAdvanced Malignant Solid NeoplasmIndolent Non-Hodgkin Lymphoma+3 more

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06223542

Observational

Testing Personalized High Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy

This study is being completed to learn if high-definition transcranial direct current stimulation (HD-tDCS) has an effect on visual and thinking abilities in p…

Posterior Cortical Atrophy

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MichiganNCT07191327

Observational

Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis - Aims 2 and 3

The goal of this pilot hybrid type I efficacy/implementation trial is to assess a newly developed decision support tool patients, parents, and providers to use…

Children With Medical Complexity (CMC)Multiple Chronic ConditionsNeuromuscular Scoliosis+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of UtahNCT07167927